Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Alcohol Clin Exp Res. 2019 Apr 8;43(5):791–802. doi: 10.1111/acer.14000

Table 1.

Putative mechanisms of action for positive allosteric modulators (PAMs) targeting specific GABAA receptor subunits

Compound Mechanism of action
Triazolam1 Nonselective benzodiazepine PAM
MRK-6962 Nonselective benzodiazepine partial PAM
QH-ii-0663 α5GABAA receptor-preferring PAM
Zolpidem1 ɑ1GABAA receptor-preferring PAM
L-838,4172 Functionally selective partial PAM at α2/3/5GABAA receptors that lacks efficacy at α1GABAA receptors (α1-sparing compound)
YT-III-314,5 Functionally selective PAM at α3GABAA receptors
YT-III-2714 Functionally selective PAM at α3GABAA receptors
HZ-1666 Functionally selective PAM at α2GABAA and α3GABAA receptors
XHe-II-0536 Functionally selective PAM at α2GABAA and α3GABAA receptors
3

Huang et al., 2003

α1/2/3/5GABAA receptors = GABAA receptors containing α1, α2, α3, and α5 subunits, respectively.